Home › Calculator › EPRX Dividend Calculator 2026
EPRX Dividend DRIP Calculator 2026
29.85% YieldHealthcareEupraxia Pharmaceuticals Inc. · NASDAQ
Price: $6.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When EPRX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your EPRX snowball 📈
$10,000 in EPRX → $136.3K in 10 years · $2,610.80/month
About Eupraxia Pharmaceuticals Inc. (EPRX) — Dividend Analysis 2026
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Compare EPRX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full EPRX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EPRX position with:
🌍 EPRX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold EPRX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 29.85% | 27.05% | $2,985 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 25.37% | 22.57% | $2,537 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 23.88% | 21.08% | $2,388 / yr |
| 🇬🇧 UK ISA | 0% | 29.85% | 27.05% | $2,985 / yr |
| 🇬🇧 UK Taxable | 8.75% | 27.24% | 24.44% | $2,724 / yr |
| 🇨🇦 TFSA | 0% | 29.85% | 27.05% | $2,985 / yr |
| 🇨🇦 CA Taxable | 25% | 22.39% | 19.59% | $2,239 / yr |
| 🇦🇺 Super (pension) | 15% | 25.37% | 22.57% | $2,537 / yr |
| 🇦🇺 AU Taxable | 30% | 20.89% | 18.09% | $2,090 / yr |
| 🇩🇪 DE Taxable | 26.375% | 21.98% | 19.18% | $2,198 / yr |
| 🇫🇷 FR Taxable | 30% | 20.89% | 18.09% | $2,090 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 EPRX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 EPRX Dividend Payment Schedule
EPRX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 EPRX vs Healthcare Benchmarks
How EPRX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EPRX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ EPRX Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EPRX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Eupraxia Pharmaceuticals Inc. (EPRX) is currently trading at $6.70, 19% below its 52-week high. The current dividend yield is 29.85% based on an annual payout of $2.00 per share.
EPRX (Eupraxia Pharmaceuticals Inc.) — 29.85% Dividend Yield Analysis
Eupraxia Pharmaceuticals Inc. (EPRX) is a healthcare stock currently trading at $6.70 with a dividend yield of 29.85%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (29.85%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.